Model of nonalcoholic steatohepatitis

American Journal of Clinical Nutrition

Volumn 79, Issue 3, 2004, Pages 502-509

  Lieber, Charles S ^a,b   Leo, Maria A ^a   Mak, Ki M ^a   Xu, Youqing ^a   Cao, Qi ^a   Ren, Chaoling ^a   Ponomarenko, Anatoly ^a   DeCarli, Leonore M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

4 hydroxynonenal; Collagen; Cytochrome P4502E1; Dietary restriction; High fat diet; Insulin resistance; Microsomes; Mitochondria; Model of nonalcoholic steatohepatitis; Oxidative stress; Tumor necrosis factor

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CONFERENCE PAPER; CONTROLLED STUDY; DIETARY INTAKE; LIPID DIET; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN INTAKE; RAT; STANDARDIZATION; ANIMAL; ARTICLE; BLOOD; DIET; DISEASE MODEL; EATING; FAT INTAKE; FATTY LIVER; GENETICS; HEPATITIS; HUMAN; INSULIN RESISTANCE; LIVER; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; SPRAGUE DAWLEY RAT;

COLLAGEN TYPE 1; CYTOCHROME P450 2E1; INSULIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMALS; COLLAGEN TYPE I; CYTOCHROME P-450 CYP2E1; DIET; DIETARY FATS; DISEASE MODELS, ANIMAL; EATING; FATTY LIVER; HEPATITIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1242290584     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/79.3.502     Document Type: Conference Paper

References (51)

1. James OFW, Day CP. Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 1998;29:495-501.
2. Yu AS, Keeffe EB. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord 2002;2:11-9.
3. Lee RG, Keeffe EB. Non-alcoholic fatty liver: causes and complications. In: Bircher J, Benhamou JP, McIntyre M, et al, eds. Oxford textbook of clinical hepatology. 2nd ed. Oxford, United Kingdom: Oxford University Press, 1999:1251-7.
4. Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc 2000;75:733-9.
5. Matteoni CA, Younossi ZM, Gramich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.
6. Fong DG, Nehra V, Lindor KD, Buchman AL. Metabolic and nutritional considerations in non-alcoholic fatty liver. Hepatology 2000;32:3-10.
7. Enriquez A, Leclercq I, Farrell GC, Robertson G. Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem Biophys Res Commun 1999;255:300-6.
8. Raucy JL, Lasker JM, Kramer JC, Salazar DE, Lieber CS, Corcoran GB. Induction of P45OIIE1 in the obese rat. Mol Pharmacol 1991;39:275-80.
9. Irizar A, Barnett CR, Flatt PR, Ioannides C. Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rats. Eur J Pharmacol 1995;293:385-93.
10. Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996;111:1645-53.
11. Lieber CS, DeCarli LM. Animal models of chronic ethanol toxicity. In: Packer L, ed. Methods in enzymology: oxygen radical in biological systems. Vol 233. Orlando, FL: Academic Press, Inc, 1994:585-94.
12. Lieber CS, Leo MA, Mak KM, et al. A model of non-alcoholic fatty liver disease (NAFLD), including steatohepatitis (NASH), in rats fed a high fat Lieber-DeCarli diet. Hepatology 2002;36:402A.
13. Taubes G. The soft science of dietary fat. Science 2001;291:2536-45.
14. Dietary intake of macronutrients, micronutrients, and other dietary constituents: United States, 1988-94. Vital Health Stat 11 2002;245.
15. Couzin J. IOM panel weighs in on diet and health. Science 2002;297:1788-9.
16. Lieber CS, DeCarli LM. Effect of drug administration on the activity of the hepatic microsomal ethanol oxidizing system. Life Sci 1970;9:267-76.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
18. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4.
19. Maniatis T, Fritch EF, Sambrook J. Gel electrophoresis. In: Maniatis T, Fritch EF, Sambrook J, eds. Molecular cloning: a laboratory manual. 1st ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982:161-75.
20. Rennard SI, Berg R, Martin GR, Foidart JM, Robey PG. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 1980;104:205-14.
21. Moshage H, Casini A, Lieber CS. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 1990;12:511-8.
22. van Kuijk FJGM, Siakotos AN, Fong LG, Stephens RJ, Thomas DW. Quantitative measurement of 4-hydroxyalkenals in oxidized low-density lipoprotein by gas chromatography-mass spectrometry. Anal Biochem 1995;224:420-4.
23. Lieber CS, Leo MA, Aleynik S, Aleynik M, DeCarli LM. Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon. Alcohol Clin Exp Res 1997;21:375-9.
24. Amenta JS. A rapid chemical method for quantification of lipids separated by thin-layer chromatography. J Lipid Res 1964;5:270-2.
25. Nouchi T, Worner TM, Sato S, Lieber CS. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease. Alcohol Clin Exp Res 1987;11:287-91.
26. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
27. Leo MA, Kim CI, Lowe N, Lieber CS. Interaction of ethanol with β-carotene: delayed blood clearance and enhanced hepatotoxicity. Hepatology 1992;15:883-91.
28. Charles River Laboratories. Life. Science, Products. Services. Wilmington, MA: Charles River Laboratories, 2002:6-10.
29. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002;35:373-9.
30. Angulo P, Lindor KD. Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issue. Gastroenterology 2001;120:1281-4.
31. Lieber CS, DeCarli LM. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 1968;162:917-8.
32. Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 1997;77:517-44.
33. Lieber CS, ed. Medical and nutritional complications of alcoholism: mechanisms and management. New York: Plenum Press, 1992:579.
34. Chalasani N, Gorski JC, Asghar MS, et al. Hepatic cytochrome P4502E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003;37:544-50.
35. Harrison SA, Kadakia S, Lang KA, Schenker S. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 2002;97:2714-24.
36. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000;105:1067-75.
37. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128-33.
38. Emery MG, Fisher JM, Chien JY, et al. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology 2003;38:428-35.
39. Teschke R, Moreno F, Petrides AS. Hepatic microsomal ethanol oxidizing system (MEOS): respective roles of ethanol and carbohydrates for the enhanced activity after chronic alcohol consumption. Biochem Pharmacol 1981;30:1745-51.
40. Yoo JSH, Ning SM, Pantuck CB, Pantuck EJ, Yang CS. Regulation of hepatic miscrosomal cytochrome P450IIE1 level by dietary lipids and carbohydrates in rats. J Nutr 1991;121:959-65.
41. Mavrelis PG, Ammon HV, Gleysteen JJ, Komorowski RA, Charaf UK. Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology 1983;3:226-31.
42. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-92.
43. Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis v. mitochondrial dysfunction in steatohepatitis. Am J Physiol 2002;282:G193-9.
44. Crespo J, Cayon A, Fernandez-Gil P, et al. Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001;34:1158-63.
45. Yin M, Wheeler MD, Kono H, et al. Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice. Gastroenterology 1999;117:942-52.
46. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-62.
47. Mofrad P, Conton MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286-92.
48. Houglum K, Filip M, Witztun JL, Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990;86:1991-8.
49. Stern JS, Gaades MD, Wheeldon CM, Borchers AT. Calorie restriction in obesity: prevention of kidney disease in rodents. J Nutr 2001;131:913S-7S.
50. Samaha FF, Iqbal N, Seshadri P, et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003;348:2074-81.
51. Foster GD, Wyatt HR, Hill JO, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003;348:2082-90.